These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16098430)

  • 1. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis.
    Kitta Y; Nakamura T; Kodama Y; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Ichigi Y; Mende A; Kugiyama K
    J Am Coll Cardiol; 2005 Aug; 46(4):648-55. PubMed ID: 16098430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease.
    Jambrik Z; Venneri L; Varga A; Rigo F; Borges A; Picano E
    Am Heart J; 2004 Oct; 148(4):684-9. PubMed ID: 15459601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of endothelial dysfunction and carotid intima-media thickness in patients undergoing coronary stent implantation.
    Corrado E; Camarda P; Coppola G; Muratori I; Ciaramitaro G; Farinella M; Novo G; Rotolo A; Andolina G; Cospite V; Evola S; Assennato P; Hoffmann E; Novo S
    Int Angiol; 2009 Feb; 28(1):12-9. PubMed ID: 19190550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation.
    Mizia-Stec K; Gasior Z; Haberka M; Mizia M; Chmiel A; Janowska J; Holecki M; Mielczarek M; Zahorska-Markiewicz B
    Kardiol Pol; 2009 Jan; 67(1):9-17; discussion 18. PubMed ID: 19253185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation.
    Patti G; Pasceri V; Melfi R; Goffredo C; Chello M; D'Ambrosio A; Montesanti R; Di Sciascio G
    Circulation; 2005 Jan; 111(1):70-5. PubMed ID: 15630038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.
    Katsaros KM; Wiesbauer F; Speidl WS; Kastl SP; Huber K; Zorn G; Niessner A; Glogar D; Maurer G; Wojta J
    Thromb Haemost; 2011 May; 105(5):883-91. PubMed ID: 21359408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention.
    Takamori N; Azuma H; Kato M; Hashizume S; Aihara K; Akaike M; Tamura K; Matsumoto T
    Circulation; 2004 Feb; 109(4):481-6. PubMed ID: 14744972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus.
    Sukhija R; Aronow WS; Sureddi R; Aleti S; Molavi B; Sachdeva R; Mehta JL
    Am J Cardiol; 2007 Sep; 100(5):777-80. PubMed ID: 17719319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study.
    Akcakoyun M; Kargin R; Tanalp AC; Pala S; Ozveren O; Akcay M; Barutcu I; Kirma C
    Coron Artery Dis; 2008 Aug; 19(5):337-43. PubMed ID: 18607171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents.
    Kubo M; Miyoshi T; Oe H; Ohno Y; Nakamura K; Ito H
    BMC Cardiovasc Disord; 2015 Sep; 15():102. PubMed ID: 26399321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bare metal stent restenosis is not a benign clinical entity.
    Chen MS; John JM; Chew DP; Lee DS; Ellis SG; Bhatt DL
    Am Heart J; 2006 Jun; 151(6):1260-4. PubMed ID: 16781233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a pressure gradient distal to implanted bare-metal stent on in-stent restenosis after percutaneous coronary intervention.
    Jensen LO; Thayssen P; Thuesen L; Hansen HS; Lassen JF; Kelbaek H; Junker A; Hansen KN; Boetker HE; Krusell LR; Pedersen KE
    Circulation; 2007 Dec; 116(24):2802-8. PubMed ID: 18025527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.
    Moldoveanu E; Mut-Vitcu B; Tanaseanu GR; Marta DS; Manea G; Kosaka T; Vidulescu C; Tanaseanu C
    Clin Biochem; 2008 Dec; 41(18):1429-33. PubMed ID: 18930040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
    Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C
    J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.